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Abstract
The brain can be viewed as a sophisticated control module for stabilizing
blood glucose. A review of classical behavioural evidence indicates that
central circuits add predictive (feedforward/anticipatory) control to the
reactive (feedback/compensatory) control by peripheral organs. The brain/
cephalic control is constructed and engaged, via associative learning, by
sensory cues predicting energy intake or expenditure (e.g. sight, smell,
taste, sound). This allows rapidly measurable sensory information (rather
than slowly generated internal feedback signals, e.g. digested nutrients) to
control food selection, glucose supply for fight-or-flight responses or pre-
paredness for digestion/absorption. Predictive control is therefore useful
for preventing large glucose fluctuations. We review emerging roles in pre-
dictive control of two classes of widely projecting hypothalamic neurones,
orexin/hypocretin (ORX) and melanin-concentrating hormone (MCH)
cells. Evidence is cited that ORX neurones (i) are activated by sensory cues
(e.g. taste, sound), (ii) drive hepatic production, and muscle uptake, of glu-
cose, via sympathetic nerves, (iii) stimulate wakefulness and exploration
via global brain projections and (iv) are glucose-inhibited. MCH neurones
are (i) glucose-excited, (ii) innervate learning and reward centres to pro-
mote synaptic plasticity, learning and memory and (iii) are critical for
learning associations useful for predictive control (e.g. using taste to pre-
dict nutrient value of food). This evidence is unified into a model for pre-
dictive glucose control. During associative learning, inputs from some
glucose-excited neurones may promote connections between the ‘fast’
senses and reward circuits, constructing neural shortcuts for efficient
action selection. In turn, glucose-inhibited neurones may engage locomo-
tion/exploration and coordinate the required fuel supply. Feedback inhibi-
tion of the latter neurones by glucose would ensure that glucose fluxes
they stimulate (from liver, into muscle) are balanced. Estimating nutrient
challenges from indirect sensory cues may become more difficult when the
cues become complex and variable (e.g. like human foods today). Conse-
quent errors of predictive glucose control may contribute to obesity and
diabetes.
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The brain can influence blood glucose levels indepen-
dently of food intake and energy expenditure. This is
illustrated, for example, by experiments where ani-
mals can be trained to lower their blood glucose in
response to arbitrary cues (reviewed and discussed in
Woods 2013). In this article, we discuss frameworks
that may unify such classic behavioural data with the
recently acquired knowledge of hypothalamic neural
circuits involved in sensing and control of glucose
levels.
The brain is thought to control blood glucose by
sending signals (via the autonomic nerves) that make
glucose shuttle between peripheral organs and the
plasma. For example, the firing of sympathetic auto-
nomic nerves can release glucose from liver stores into
the blood, while parasympathetic nerves can stimulate
the pancreas to produce insulin to lower blood glu-
cose. A distinct property of this neural glucose control
is that it is not just a reactive/corrective response to a
change in glucose that already occurred. It is an antic-
ipatory action based on an estimation of a future
change in glucose level (Teff 2011, Woods 2013), that
is a Pavlovian-like process (Pavlov 1902). Indeed, the
lateral hypothalamus, which controls food choice and
glucose levels as described below, also contains neuro-
nes that respond to food-associated cues (sight, taste)
during hunger but not satiety, that is only when the
animal is likely to ingest the food (Burton et al. 1976,
Mora et al. 1976, Rolls et al. 1976).
Forward-planning actions of the brain (e.g. releas-
ing insulin before food ingestion, Power & Schulkin
2008) would make glucose control more efficient,
which can be viewed as an evolutionary advantage.
Such actions are best known by terms ‘anticipatory’
or ‘cephalic’ in physiology, but are conceptually simi-
lar to feedforward/predictive controls in other evolv-
able systems (Franklin & Wolpert 2011, DiStefano
et al. 2012). In this review, we will use ‘predictive’ to
mean feedforward/anticipatory/cephalic. The general
arrangement and usefulness of predictive and reactive
controls is illustrated in Figure 1. A key advantage of
reactive control (such as of glucose levels by the pan-
creas) is often described as disturbance resistance of
controlled parameter (glucose level), which arises from
self-correcting nature of feedback (Fig. 1a). A key dis-
advantage of feedback control is slowness, as it
requires many steps: an event (eating), change in con-
trolled parameter (glucose), sensing of this change by
controller (pancreas) and reaction of controller (insu-
lin release). Feedforward control has a complementary
set of advantages and disadvantages: it is fast but
blind to its output (Fig. 1b). A predictive controller
triggers control actions before the event, usually using
neutral ‘event cues’ (e.g. a sudden noise) to drive
anticipatory actions, such as hepatic glucose release to
fuel potential escape actions. Together, predictive and
reactive strategies thus form a useful control scheme,
both fast and self-correcting. This could be an evolu-
tionary rationale for why the peripheral organs and
the brain came to cooperate in controlling glucose lev-
els (Fig. 1c).
In this review, we try to unify this general logic of
control with specific experimental knowledge of brain
neurocircuits regulating glucose levels. For good pre-
dictive control, the brain has to estimate how likely
an event (or a neutral event cue) is to change blood
glucose level. This requires associative learning, and
the ability to refine and update it based on experience
(in this case, experience of actual glucose changes).
We will discuss a circuit model where predictive con-
trol, including associative learning, is linked to glu-
cose-sensing neurones. As background for this model,
we first review experimental data on brain glucose-
sensing neurones. Our overall intention is to discuss a
general systems view (von Bertalanffy 2013) of brain
glucose control and glucose-sensing neurones. For
more comprehensive account of cellular/molecular
components and processes controlling energy balance,
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Figure 1 Canonical schemes for reactive (a) and predictive
(b) adjustments in the context of glucose level control. Com-
bining reactive and predictive control (c) overcomes limita-
tions of individual control modes.
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the reader is referred to other sources (e.g. Berthoud
2011, Yeo & Heisler 2012, Petrovich 2013). Although
we do not discuss all known data, to the best of our
knowledge, current experimental measurements do
not contradict the hypotheses outlined here.
Glucose-sensing neurones and physiological
changes in extracellular glucose levels
Discovery of glucose-sensing neurones in brain areas
such as the hypothalamus, brain stem and substantia
nigra suggested that the brain can directly monitor
body energy status (Anand et al. 1964, Oomura et al.
1969, 1974, Yuan et al. 2004). The firing of ‘glucose-
excited’ and ‘glucose-inhibited’ neurones is steeply
tuned within ambient glucose range (e.g. 1–5 mM,
Burdakov et al. 2005). This concentration range is
above saturation of ubiquitous glucose transporters
and hexokinases (Qutub & Hunt 2005). Glucose-sens-
ing responses are thus distinct from ubiquitous silenc-
ing of neurones by low glucose (Fig. 2). They are not
seen in most neurones in the brain, whose glucose-
phosphorylating enzymes are thought to have km val-
ues of around 40 lM, and so presumably saturate and
do not change intracellular energy levels upon glucose
fluctuations >1 mM (Qutub & Hunt 2005).
Biophysical properties of glucose-sensing neurones,
their similarities to peripheral glucose-sensing cells
such as pancreatic insulin-secreting cells and the still
unclear intracellular transduction mechanisms for glu-
cose-sensing have been discussed in other recent
reviews (Mobbs et al. 2001, Routh 2002, Karnani &
Burdakov 2011). Here, we only briefly recapitulate
the evidence that brain glucose levels change within a
range sensed by glucose-sensing neurones. In rodents,
simultaneous measurements of glucose in brain and
blood show that brain glucose levels are generally 10–
30% of blood glucose levels (Silver & Erecinska
1994, Routh 2002, Dunn-Meynell et al. 2009). How-
ever, in this lower range, brain glucose levels rapidly
follow changes in blood glucose levels (Silver & Erec-
inska 1994). At euglycemia, brain glucose levels are
thought to be around 0.7–2.5 mM (Routh 2002). A
maximum of around 5 mM may be reached during
severe plasma hyperglycaemia, while during hypo-
glycaemia, brain glucose may fall to 0.2–0.5 mM
(Silver & Erecinska 1994). A point of continuing con-
troversy is whether brain glucose levels approach
blood glucose levels near areas of high permeability in
the blood–brain barrier (circumventricular organs),
such as the median eminence in the hypothalamus
(Ganong 2000). It has recently been shown that this
may not apply to neurones in close vicinity, such as
the arcuate nucleus (ARC) in the case of median emi-
nence (Dunn-Meynell et al. 2009), perhaps, because
of tanycyte cell barriers between the ARC and median
eminence (Mullier et al. 2010; Peruzzo et al. 2000).
Meals are thought to increase blood glucose and
thus also brain glucose, but the extent to which this
happens depends on macronutrient content (Jenkins
et al. 1981). Generally, meals high in protein or fat
elevate blood glucose less than carbohydrate-rich
meals. Another source of blood glucose is glucose
release from the liver, which is also under brain con-
trol as discussed below. Hepatic glucose release is reg-
ulated by insulin and glucagon as well as, but to a
lesser extent, directly by the autonomic nerves (Pu-
schel 2004). Finally, blood glucose is also influenced
by glucose uptake into muscle and adipose tissues,
which is increased by insulin and sympathetic activity
(Nonogaki 2000).
Thus, current evidence suggests that glucose-sensing
neurones may sense physiological changes in ambient
glucose (and in turn, control glucose levels via feeding
and autonomic nerves, see below). Recent examina-
tions of neurochemical identities of glucose-sensing
neurones revealed diverse cells groups. For example,
in the hypothalamus, glucose-inhibited neurones are
thought to comprise anatomically and functionally
distinct subgroups, for example neurones containing
orexin/hypocretin (ORX, in the lateral hypothalamus),
NPY/AgrP (in the hypothalamic arcuate nucleus), and
SF-1 (in the hypothalamic ventromedial nucleus). Glu-
cose-excited neurones may include POMC neurones
(in the arcuate nucleus) and melanin-concentrating-
hormone, (MCH, in the lateral hypothalamus) (Kar-
nani & Burdakov 2011). Some brain areas outside the
lateral and mediobasal hypothalamus have also been
shown to contain glucose-sensing neurones (Ritter
et al. 1981, Adachi et al. 1984, Melnick et al. 2011),
but their identities are incompletely understood.
In this review, we will limit our discussion to MCH
and orexin neurones of the lateral hypothalamus and
attempt to present experimental knowledge about
their functions within a broader context of predictive
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Figure 2 Graphical depiction of ubiquitous responses to low
glucose vs. specialized glucose-sensing responses of neurones.
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glucose control by the brain. We acknowledge that it
is not yet clear whether other glucose-sensing neuro-
nes are conceptually similar to the roles of orexin and
MCH cells hypothesized here and whether orexin and
MCH neurones function as homogenous or heteroge-
nous populations in relation to glucose control.
MCH neurones and predictive control
Recent data suggest that MCH neurones are essential
for learning to select nutritionally superior foods
based on taste, a useful predictive operation (Domin-
gos et al. 2013). Taste itself is a neutral cue; it has no
nutrient value. However, it can be rapidly detected by
tongue receptors, making it a useful trigger for predic-
tion-based actions (such as food choice), after learning
that eating foods with certain tastes produces nutri-
ents. The animal may thus learn a more time-efficient
food selection strategy, by developing a ‘cognitive
shortcut’ directly from taste to food selection. The
basic idea suggested by recent experiments (reviewed
below) is that activation of MCH neurones – possibly
in part by glucose – is an essential permissive signal
for building such a shortcut inside the brain. We first
review basic properties of MCH neurones relevant to
this role. Then, we put them into the context of using
nutrient value of sugar to construct predictive control
circuits for ingestive behaviour.
Neurochemical, anatomical and behavioural overview of
MCH neurones
MCH-expressing neurones are located exclusively in
the lateral hypothalamus, but project widely through-
out the brain (Bittencourt 2011). At their projection
targets, MCH neurones are thought to release
inhibitory transmitters. These transmitters include
MCH-related peptides (which act on specific
G-protein-coupled receptors), as well as GABA, whose
release during MCH cell firing can affect target neuro-
nes very fast (milliseconds), by activating GABA-A
receptors (Jego et al. 2013).
Like ORX, MCH has been often viewed as a feed-
ing–promoting transmitter. However, in many ways,
actions of MCH cells appear the opposite to those of
ORX cells. For example, knockout of MCH in mice
increases energy expenditure and reduces body weight
(Shimada et al. 1998), which is recapitulated by
knockout of the MCH receptor MCH1R, the only
known MCH receptor in mice (Marsh et al. 2002).
MCH neurones are thought to fire mostly during
REM sleep, whereas ORX neurones are thought to
fire mostly during active waking (Hassani et al. 2009,
2010). Brain injection of MCH promotes sleep,
as does optogenetic stimulation of MCH neurones
(Verret et al. 2003, Jego et al. 2013, Konadhode et al.
2013), while deletion of MCH or MCH1R leads to
increased locomotor activity (Zhou et al. 2005). Thus,
endogenous MCH may promote sleep and suppresses
locomotor activity and energy expenditure, that is the
opposite of actions of ORX. While MCH neurones
are often called ‘appetite promoting’, their role in
food intake is not completely obvious. Knockout of
MCH in (nocturnal) mice increases food intake during
the day, but not during the night (Shimada et al.
1998). Not all (Presse et al. 1996) studies show that
MCH increases food intake, and mice lacking
MCHR1 actually have increased food intake (Chen
et al. 2002, Marsh et al. 2002).
There is a growing realization that glucose homeo-
stasis and metabolic health depend on sleep patterns
(Bass & Takahashi 2010, Reddy & O’Neill 2010).
Good predictive control requires learning, which is also
closely linked to sleep (Diekelmann & Born 2010). In
this context, it is interesting that the firing of MCH
neurones has been recently causally liked to sleep (Jego
et al. 2013, Konadhode et al. 2013). Activation of
MCH neurones could prolong REM sleep episodes,
while silencing MCH neurones led to termination of
REM (Jego et al. 2013). This raises an intriguing possi-
bility that electrical activity of MCH cells is necessary
and sufficient for REM sleep. Release of both GABA
and MCH peptides from MCH cells, on targets such as
wake-promoting hypothalamic histamine neurones as
well as hippocampal circuits, is probably involved in
this sleep control (Jego et al. 2013). Interestingly,
MCH also increases the beat frequency of cilia lining a
part of the third ventricle (Conductier et al. 2013), sug-
gesting that it may sustain CSF movement and circula-
tion during REM sleep, when body movement is
minimal due to REM-associated muscle atonia.
Glucose sensing and control by MCH neurones
Physiologically relevant increases in local extracellular
glucose levels have been shown to excite MCH neuro-
nes in mouse brain slices (Burdakov et al. 2005, Kong
et al. 2010). More recently, this excitation has been
shown to involve glucose-dependent closure of Kir6.2/
SUR1-containing ATP-inhibited K+ (K-ATP) channels
(Kong et al. 2010). Expression of ATP-resistant
K-ATP channels selectively in MCH neurones ablated
MCH cell glucosensing and impaired glucose toler-
ance (Kong et al. 2010). While this suggests that glu-
cose excitation of MCH neurones may improve
glucose tolerance, the acute v chronic role of MCH
neurones in glucose control is unclear at present. For
example, although glucose tolerance worsens if MCH
cells are made glucose-insensitive from birth (Kong
et al. 2010), it actually improves if MCH cells are
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destroyed in the adult (Whiddon & Palmiter 2013).
Furthermore, MCH overexpression leads to obesity
and insulin resistance (Ludwig et al. 2001) and
increases insulin levels (Pissios et al. 2007). It is possi-
ble that, like ORX neurones, MCH cells could have
multiple, differentially modulated effects on glucose
release and uptake. Alternatively, as discussed below,
the actions of MCH neurones could be more central
for coordinating predictive glucose control, rather
than for reactive responses to increased glucose levels.
MCH neurones, learning and memory
Learning, especially formation of associative memo-
ries, is a prerequisite for good predictive control.
Among projection targets of MCH neurones are sev-
eral memory-related structures, including the hippo-
campus and septum (Adamantidis & de Lecea 2009,
Jego et al. 2013), where activation of MCH receptors
may promote synaptic strengthening (Pachoud et al.
2010). MCH neurones directly project to the hippo-
campal formation and may regulate hippocampal
function through the medial septum nucleus. Sleep is
thought to be important for memory, and release of
acetylcholine in the hippocampus is considered vital
for memory consolidation. Central administration of
MCH peptide has been shown to prolong REM and
non-REM sleep episodes and to increase hippocam-
pal, but not cortical, acetylcholine release (Lu et al.
2013).
MCH neurones and associative learning for predictive
control
As outlined above, good predictive control requires
learning an association between a neutral but easily
measurable parameter (‘conditioned stimulus’ in psy-
chology) and actual nutrient value of food (‘uncondi-
tioned stimulus’, cannot be measured quickly for most
food). Subsequently, detection of a conditioned stimu-
lus can be used for efficient (i.e. rapid) action selection
and for preparing the body for subsequent slower arri-
val of glucose to blood. Recent experimental evidence
suggests that MCH neurones are a key part of such
associative learning.
For example, Sherwood et al. found that genetic or
pharmacological disruption of the MCH receptor
(MCH-1R) reduced the ability of a previously learnt
conditioned stimulus to serve as a reinforcer in a new
instrumental behaviour task (Sherwood et al. 2012).
This raises the possibility that MCH signalling may be
important for the response transfer in dopamine neu-
rones (Schultz et al. 1997), which shift their activity
from occurrence of the reward to the earliest condi-
tioned stimulus, while the stimuli closer to the reward
(e.g. taste) serve as conditioned reinforcers for earlier
occurring stimuli (e.g. colour, shape of food).
More recently, Domingos et al. (2013) obtained
data suggesting that MCH neurones are necessary for
a conditioned stimulus, taste, to evoke brain reward
signals (and thus presumably action selection). In these
experiments, mice naturally preferred calorie-contain-
ing sucrose to non-caloric sweetener sucralose. This is
thought to be because metabolisable sugar enabled
sweet taste to generating a brain reward signal, dopa-
mine (Domingos et al. 2013). Optogenetic stimulation
of MCH neurones effectively substituted for metabo-
lizable sugar, so mice came to prefer sucralose when
its consumption was paired with MCH neurone activa-
tion (Domingos et al. 2013). This suggests that MCH
neurone activation [presumably at least in part by glu-
cose as tasting artificial sweeteners does not activate
MCH neurones (Shiuchi et al. 2009)] instructs reward
learning when sweet taste leads to nutrients. Loss of
MCH neurones stopped mice from preferring sucrose
to sucralose. These data are consistent with conclu-
sions of an earlier pharmacological study showing that
blocking the MCH receptor reduces lever pressing
reinforced by sucrose, but not lever pressing reinforced
by artificial sweetener (Karlsson et al. 2012).
In mice with normal sweet taste receptors, activa-
tion of MCH neurones did not drive reward unless
sweet taste receptors were also stimulated (Domingos
et al. 2013), suggesting that in normal mice, both
MCH neurones and taste are required for establishing
a behavioural preference. This implies the existence of
conditional switch circuits (also called AND logic
gates) that either allow MCH neurones to be activated
by sugar only when taste input is present, or allow
dopamine release only when both MCH input and
taste input are present. Currently, the latter seems
more likely, because in normal mice, MCH neurone
activation did not drive DA release and behavioural
preference without taste (Domingos et al. 2013).
However, there are probably alternative pathways
(not involving taste signalling) for enabling MCH neu-
rones to facilitate food preference, as ‘sweet-blind’
Trpm5-/- mice learn to prefer sucrose to sucralose in a
manner dependent on MCH neurones (Domingos
et al. 2013).
Overall, current evidence therefore suggests that, by
controlling synaptic plasticity, MCH neurones may
gate the ability of neutral cues (e.g. taste) to elicit
brain reward and action selection, presumably based
on associated changes in energy levels (Fig. 3a).
ORX neurones and predictive control
ORX neurones are activated by diverse stimuli that
are of no nutrient value themselves, but may indicate
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that energy intake or expenditure is imminent [e.g.
sounds, sweet taste, stress (Mileykovskiy et al. 2005,
Shiuchi et al. 2009, Winsky-Sommerer et al. 2004)].
This fits the operational definition of predictive con-
trol action, considering that ORX neurones stimulate
many ‘fight-or-flight’ physiological responses [e.g.
arousal, sympathetic drive, heart rate, flux of glucose
from liver to muscles (Karnani & Burdakov 2011,
Kuwaki 2011, Grimaldi et al. 2014)]. Below, we
review experimental investigations of ORX cell prop-
erties, from a viewpoint that ORX neurones are part
of predictive trigger circuits for adaptive physiological
responses.
Neurochemical, anatomical and behavioural attributes
of ORX neurones
ORX neurones have been subject of detailed recent
reviews (de Lecea et al. 2006, Sakurai 2007) and are
introduced only briefly here. Like MCH neurones, in
the brain, ORX neurones are located exclusively in
the lateral hypothalamus, from which they innervate a
long list of cortical and subcortical brain areas (Pey-
ron et al. 1998), including the cerebellum (Nisimaru
et al. 2013). A net impact of ORX neurone on physio-
logical set points can be summarized as keeping mam-
mals ‘thin and awake’, as loss of ORX neurones
produces narcolepsy and obesity (Hara et al. 2001,
Dauvilliers et al. 2007). ORX neurones are not neces-
sary for wakefulness per se, but are essential for stabi-
lizing wakefulness into sustained episodes required for
many behaviours. Thus, animals deficient in ORX
neurones (or ORX type 2 receptors) still display rela-
tively normal amounts of total sleep and total wake
time; however, their wakefulness (and sleep) are frag-
mented (Hara et al. 2001). ORX neurones are there-
fore considered to be essential for adjusting arousal to
the environment, as ORX-deficient narcoleptic ani-
mals (and humans) experience irresistible attacks of
sleep. Causes of ORX cell loss in human narcolepsy
are still debated, but increasingly thought to be at
least partly autoimmune (De la Herran-Arita et al.
2013, Mahlios et al. 2013).
ORX neurones exert their effects on downstream
circuits via two specific G-protein-coupled receptors
for ORX peptide neurotransmitters (Sakurai 2007), as
well as via release of glutamate that alters target neu-
rone firing on a millisecond timescale (Sch€one et al.
2012). The type 2 ORX receptor is particularly criti-
cal for stable wakefulness (Lin et al. 1999, Willie
et al. 2003), whereas type 1 ORX receptor has been
proposed to regulate reward and addiction (Boutrel
et al. 2005, Cason & Aston-Jones 2013a,b, Mahler
et al. 2013). The role of ORX neurones in driving
reward seeking is well established, but many details
(e.g. whether there are segregated ‘arousal’ and
‘reward’ ORX circuits) remain unclear and are under
active investigation (Harris & Aston-Jones 2006, de
Lecea et al. 2006, Gonzalez et al. 2012). It is gener-
ally agreed, however, that ORX neurones can engage
arousal and reward-seeking drive together, leading to
exploratory behaviour. At the same time, ORX neuro-
nes stimulate breathing, circulation, glucose release
from liver and glucose uptake by muscle, presumably
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Figure 3 Cell-based models for orchestrating predictive glu-
cose control by melanin-concentrating hormone (a) and orex-
in (ORX) (b) neurones. In a, dashed line with question mark
shows hypothetical negative signal from reward cells
(unknown, not discussed here) that might be required for
controlling learning based on existing and future associations
(Schultz & Dickinson 2000). In b, Cue-ORX coupling might
also be subject to learning via unknown pathways not dis-
cussed here. Arrows depict excitation, and t-bars depict inhi-
bition.
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to orchestrate energy supply for exploratory or escape
behaviour (reviewed in detail in Grimaldi et al. 2014,
Karnani & Burdakov 2011). Data about the activity
profile of ORX neurones in vivo across behavioural
states are sparse, but are consistent with the latter role
of ORX cells, with higher activity during active wak-
ing, lower activity during quiet waking and little
activity during sleep (Lee et al. 2005, Mileykovskiy
et al. 2005).
Activation of ORX neurones by cues predicting
imminent glucose change
The firing of ORX neurones stimulates awakening
(Adamantidis et al. 2007). However, during wakeful-
ness, ORX neurones are not uniformly active and
often show periods of complete silence (Mileykovskiy
et al. 2005). Their firing is thus not essential for
wakefulness per se, but is thought to boost wakeful-
ness when demanded by the environment. ORX neu-
rones are activated by diverse stimuli that may
demand increased arousal, energy expenditure and
goal-oriented behaviour, for example sudden sounds,
tasting of artificial sweeteners, stress, hypoglycaemia
and hypercapnia (Yamanaka et al. 2003, Winsky-
Sommerer et al. 2004, Mileykovskiy et al. 2005,
Williams et al. 2007, Shiuchi et al. 2009). A common
feature of these stimuli is that they predict a change in
glucose consumption, which is likely to be needed to
overcome an imminent challenge. This suggests that
ORX neurones are an essential part of a predictive
control circuit that primes the brain and the body for
action, even in response to neutral stimuli such as
sounds. Indeed, when actions of ORX neurones are
experimentally suppressed, key predictive adaptations
to the environment are reduced, such as blood
pressure rises in resident-intruder tests’ and fasting-
induced exploration (Kayaba et al. 2003, Yamanaka
et al. 2003).
Inhibition of ORX neurones by glucose
Measurements of genetic markers of neuronal activa-
tion and of ORX mRNA levels following in vivo
manipulation of glucose levels suggest that ORX neu-
rones are activated by hypoglycaemia and are thus
‘glucose-inhibited’, considering they do not directly
respond to insulin (Moriguchi et al. 1999, Cai et al.
2001, Yamanaka et al. 2003). Initially, it was found
that orexin-A/hypocretin-1 was not present in glucose-
inhibited neurones of the lateral hypothalamus (Liu
et al. 2001), and a more recent electrophysiological
study also failed to observe glucose responses in rat
ORX neurones (Parsons & Hirasawa 2010). How-
ever, at least three different groups reported robust
acute inhibition of ORX neurones by glucose, using
calcium imaging of rat ORX cells, or patch-clamp
recordings from mouse ORX cells (Muroya et al.
2001, Yamanaka et al. 2003, Williams et al. 2008,
Guyon et al. 2009).
The discrepancies between different groups’ data on
glucose-sensing capability of ORX neurones may be
related to two experimentally documented features of
this sensing response: adaptation and context depen-
dence. In vitro, some ORX cells can adaptively reduce
their glucose-stimulated K+ conductance when glucose
levels are stable. After an inhibition caused by a glu-
cose rise, they intrinsically reset to their prior excit-
ability level even though glucose is still ‘up’ (Williams
et al. 2008). Such stimulus adaptations are common
across sensory systems (Carpenter 2003) and may help
ORX cells to maintain glucose-trend sensing irrespec-
tive of basal glucose level (Williams et al. 2008). The
context dependence of ORX cell glucose sensing is
illustrated by in vitro findings that their ability to
sense glucose dose dependently disappears upon
increased levels of lactate, pyruvate or ATP (Venner
et al. 2011), upon reduced extracellular pH (Burdakov
et al. 2006) or (through pH-independent effects) by
the presence of nutritionally relevant mixes of dietary
amino acids (Karnani et al. 2011). Thus, under some
circumstances, ORX cells may turn off their glucose-
sensing ability in favour of integrating other signals.
Overall, current evidence therefore suggests that
ORX neurones are part of a predictive–reactive cir-
cuit, which can output arousal and energy for poten-
tial actions based on neutral cues, but is also subject
to feedback inhibition by some of these outputs
(Fig. 3b).
Unifying model for glucose-sensing neurones
and predictive–reactive glucose control
The reviewed evidence suggests that glucose-excited
and glucose-inhibited neurones are an integral part of
predictive glucose control by the brain (Fig. 4). More
specifically, we hypothesize that during associative
learning, inputs from some glucose-excited neurones
may promote connections between the ‘fast’ senses
and brain reward circuits. This would enable reward
signals to be generated in response to cue rather than
to later outcome (Schoenbaum et al. 2013), thereby
constructing neural shortcuts for efficient action selec-
tion. Apart from glucose-excited MCH neurones
reviewed above, other glucose-excited neurones may
also contribute to this. For example, glucose-excited
POMC neurones of the hypothalamic arcuate nucleus
innervate memory and reward centres (O’Donohue
et al. 1979), and peptides they release are implicated
in synaptic plasticity (Caruso et al. 2014).
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In turn, glucose-inhibited neurones may engage loco-
motion/exploration and coordinate the required fuel
supply. Feedback inhibition of the latter neurones by
glucose would ensure that glucose fluxes they stimulate
(from liver, into muscle) are balanced (Fig. 4). Apart
from glucose-inhibited ORX neurones reviewed above,
other putative glucose-inhibited neurones may also
play this role, for example SF-1 neurone of the ventro-
medial hypothalamus (Karnani & Burdakov 2011).
Questions, limitations and implications
Our model unifies diverse experimental data with a
control framework for improving glucose control. It is
hoped that this may produce a clearer view of out-
standing questions and discrepancies, and help to gen-
erate testable hypotheses. Many unknowns remain.
For example, currently available data suggest that
MCH cell firing, which enables taste to drive reward
(Domingos et al. 2013), occurs only during sleep,
especially REM sleep (Hassani et al. 2009). Does this
mean that associative learning for predictive glucose
control occurs only during sleep? Current data also
suggest that MCH cells help to construct predictive
control circuit in the brain (Domingos et al. 2013),
but in contrast to ORX neurones, MCH cells are not
themselves activated by neutral cues such as taste
(Shiuchi et al. 2009, Petrovich et al. 2012). It is also
not clear whether learning plays a role for the
predictive adaptations initiated by ORX neurones, but
it might be possible as orexin/ataxin-3-transgenic mice
show impaired long-term potentiation in hippocampus
(Yang et al. 2013); and in the VTA, drug-induced
plasticity of glutamate synapses onto dopamine neuro-
nes can be promoted by orexin (Baimel et al. 2014).
Do ORX and MCH neurones operate simultaneously
and in parallel or are their actions segregated in time,
as suggested by their reciprocal firing profiles during
sleep and wakefulness (Hassani et al. 2009), and the
finding that MCH neurones are inhibited by direct
projections from histaminergic neurones in wake-pro-
moting regions (Parks et al. 2014)?
We did not explicitly discuss circuitry for updating
associations involving MCH neurones [e.g. via predic-
tion error-based learning, (Schultz & Dickinson
2000)], or the role of learning in predictive circuit
involving ORX neurones. Little experimental data
currently exist on these vital aspects of hypothalamic
control systems, but additional cells and processes are
likely to be required to account for this (Schultz &
Dickinson 2000). Delineating these circuits would be
important for understanding how predictive beliefs
about food can be reshaped. We also note that,
although it is clear that ORX and MCH neurones are
involved in predictive control, little data yet exist
(with the exception of Kong et al. 2010) quantifying
the impact of their direct glucose responses on glucose
control efficiency.
Muscle
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Figure 4 Block diagram model for orchestration of central and peripheral processes by glucose-sensing neurones, in the context
of reactive and predictive control of glucose levels. Glucose-inhibited neurones, such as orexin cells, may facilitate exploration
identify prospective nutrient sources. Glucose-excited neurones, such as melanin-concentrating hormone cells, may facilitate
exploitation of prior knowledge for efficient food selection based on ‘fast’ (readily measurable) cues. Glucose level may thus
shift the balance between exploration and exploitation.
© 2014 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society,
doi: 10.1111/apha.1236014
Predictive models of glucose control · C Kosse et al. Acta Physiol 2015, 213, 7–18
Viewing central regulation of glucose as predictive
control has implications for identifying origins of
metabolic disease. Predictive control works best when
associations between neutral stimuli (e.g. colour of
food) and caloric value are consistent and so can be
readily learnt and used for accurate predictive actions
(e.g. releasing X amount of insulin upon seeing a red
apple). Many of these associations were presumably
quite stable on an evolutionary timescale. They are
no longer fixed in the modern environment filled
with diverse and rapidly changing food packaging
and advertising (e.g. calorically identical food can
come in many different packages), and artificial
flavours mimicking taste without providing caloric
value. Presumably, this poses a problem for predic-
tive control, because estimating nutrient challenges
from indirect sensory cues becomes different in this
complex environment. Frequent errors of predictive
control can presumably put a strain on reactive
controllers (liver and pancreas) that correct these
errors. We hypothesize that predictive control errors
may contribute to the development of obesity and
diabetes.
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